EMAIL THIS PAGE TO A FRIEND

Journal of Cancer

The Regulation of Matrix Metalloproteinase Expression and the Role of Discoidin Domain Receptor 1/2 Signalling in Zoledronate-treated PC3 Cells.


PMID 26366216

Abstract

Discoidin Domain Receptors (DDR1/DDR2) are tyrosine kinase receptors which are activated by collagen. DDR signalling regulates cell migration, proliferation, apoptosis and matrix metalloproteinase (MMP) production. MMPs degrade extracellular matrix (ECM) and play essential role in tumor growth, invasion and metastasis. Nitrogen-containing bisphosphonates (N-BPs) which strongly inhibit osteoclastic activity are commonly used for osteoporosis treatment. They also have MMP inhibitory effect. In this study, we aimed to investigate the effects of zoledronate in PC3 cells and the possible role of DDR signalling and downstream pathways in these inhibitory effects. We studied messenger RNA (mRNA) and protein expressions of MMP-2,-9,-8, DDR1/DDR2 type I procollagen (TIP) and mRNA levels of PCA-1, MMP-13 and DDR-initiated signalling pathway players including K-Ras oncogene, ERK1, JNK1, p38, AKT-1 and BCLX in PC3 cells in the presence or absence of zoledronate (10-100 μM) for 2-3 days. Zoledronate (100 μM) down-regulated DDR1/ DDR2, TIP mRNAs but did not change MMP-13 (collagenase-3) mRNA. However, zoledronate up-regulated MMP-8 (collagenase-2) mRNA. Zoledronate also inhibited mRNA expressions of K-Ras, ERK1, AKT-1, BCLX and PCA-1; but did not change JNK1, p38 mRNA levels. Zoledronate (100 μM) supressed DDR1/DDR2, TIP expressions; and gelatinase (MMP-2/MMP-9) expressions/activities. Conversely, zoledronate up-regulated MMP-8 expression in PC3 cells. Zoledronate down-regulates MMP-2/-9 expressions in PC3 prostate cancer cells. DDR1/DDR2 signalling and DDR-initiated downstream Ras/Raf/ERK and PI3K/AKT pathways may at least partially responsible for MMP inhibitory effect of zoledronate.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

AV38791
Anti-HTATIP antibody produced in rabbit, affinity isolated antibody
SAB2103488
Anti-HTATIP antibody produced in rabbit, affinity isolated antibody
SAB2104133
Anti-HTATIP, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB1408039
Anti-ITFG1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA015590
Anti-ITFG1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab1
HPA019728
Anti-ITFG1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab2
SAB2101183
Anti-ITFG1 antibody produced in rabbit, affinity isolated antibody
SAB1407003
Anti-KAT5 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA016953
Anti-KAT5 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2106496
Anti-KAT5 antibody produced in rabbit, affinity isolated antibody
HPA035421
Anti-METTL8 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4500117
Anti-TIP60 antibody produced in rabbit, affinity isolated antibody
SAB4500118
Anti-TIP60 antibody produced in rabbit, affinity isolated antibody
SAB4500119
Anti-TIP60 antibody produced in rabbit, affinity isolated antibody
SAB2501495
Anti-TIPRL (C-terminal) antibody produced in goat, affinity isolated antibody, buffered aqueous solution
HPA027995
Anti-TIPRL antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB5300083
Monoclonal Anti-KAT5 antibody produced in mouse, clone 3F9, ascites fluid
SAB4100104
Monoclonal Anti-TIPRL antibody produced in mouse, clone TIPRL-A80, culture supernatant